Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
Selective targeting of GPR176 as a paradigm for the development of novel renal anti-fibrotic drugs
Denby, Laura
(Principal Investigator)
Deanery of Clinical Sciences
Overview
Fingerprint
Research output
(1)
Project Details
Status
Finished
Effective start/end date
1/06/19
→
30/11/24
Funding
Kidney Research UK:
£483,863.66
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Beta Adrenergic Receptor Blocking
Medicine and Dentistry
100%
Morphology
Medicine and Dentistry
100%
Experimental Uremia
Medicine and Dentistry
100%
Chronic Kidney Failure
Pharmacology, Toxicology and Pharmaceutical Science
100%
Heart Failure
Pharmacology, Toxicology and Pharmaceutical Science
100%
Animal
Pharmacology, Toxicology and Pharmaceutical Science
75%
Chronic Kidney Disease
Medicine and Dentistry
57%
Beta Adrenergic Receptor Blocking Agent
Pharmacology, Toxicology and Pharmaceutical Science
50%
Research output
Research output per year
2023
2023
2023
1
Article
Research output per year
Research output per year
Beta Blockade Prevents Cardiac Morphological and Molecular Remodelling in Experimental Uremia
Chinnappa, S.
,
Maqbool, A.
,
Viswambharan, H.
,
Mooney, A.
,
Denby, L.
&
Drinkhill, M.
,
27 Dec 2023
,
In:
International Journal of Molecular Sciences.
25
,
1
, 373.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Beta Adrenergic Receptor Blocking
100%
Morphology
100%
Experimental Uremia
100%
Chronic Kidney Failure
100%
Heart Failure
100%